New President of Nobel Biocare announced

Nobel Biocare’s new president has been announced by Envista Holdings Corporation as Mr. Stefan Nilsson. 

Most recently, Mr. Nilsson served as CEO of Colosseum Dental Group, which grew to be one of Europe's largest Dental Service Organizations under his leadership. Prior to Colosseum, Mr. Nilsson was CEO of GrandVision Brazil, a leading eyecare service provider. Further, he had a distinguished career at Nestlé in a variety of operations, marketing, and general management roles around the world. 

Envista's CEO Mr. Paul Keel said, "It is my pleasure to welcome Stefan to Envista. As CEO of Colosseum Dental Group, Stefan led the company through a period of rapid growth and value creation. He has deep insights into the ever-evolving needs of our customers, and he is a passionate advocate for the digitization of dental workflows. I look forward to working with Stefan to accelerate growth at Nobel Biocare and further position us as a global leader in implant dentistry." 

Mr. Nilsson said, "It is an honor to join Envista as President of Nobel Biocare, the premier brand in implants. Nobel Biocare is the pioneer of implant innovation and well positioned to lead the future of this specialty. As a customer, I saw firsthand the strength of Nobel Biocare's innovation, their best-in-class clinical solutions, and the vibrant community of clinicians around the brand. I am delighted to be working with the Nobel Biocare team and our clinical partners to further advance our business and the future of implant dentistry." 

The announcement came alongside two other Envista Holdings Corporate leadership appointments – Veronica Acurio Envista as President, Ormco, and Eric Hammes, the new Chief Financial Officer. 

"It is a pleasure to welcome this trio of successful leaders to Envista," said Paul Keel. "Each brings experience in dental along with a proven track record of continuous improvement, leading with purpose, and creating value for all stakeholders. Today's announcement positions Envista even more strongly to advance our mission of partnering with dental professionals to improve patient lives."

Media contacts

Nobel Biocare
Chris Kendall, Senior Manager Public Relations, Nobel Biocare
Email: christopher.kendall@envistaco.com

Envista Holdings Corporation
Melissa Morrison, Vice President, Communication 
200 S. Kraemer Blvd., Building E 
Brea, CA 92821
United States 
Telephone: (714) 817-7000
 

Nobel Biocare is a world leader in the field of innovative implant-based dental restorations. The company's portfolio offers solutions from single tooth to fully edentulous indications with dental implant systems (including Nobel Biocare N1™, NobelActive®, NobelParallel™, and the All-on-4® treatment concept), a comprehensive range of high-precision individualized prosthetics and CAD/CAM systems (NobelProcera®), prefabricated prosthetics, and a wide variety of regenerative solutions (creos™). Products are supported by a single digital platform for imaging, diagnostics, and treatment planning (DTX Studio™ suite), and guided and navigated surgery (NobelGuide® and X-Guide®). Nobel Biocare supports its customers through all phases of professional development, offering world-class training and education along with practice support and patient information materials. The company is headquartered in Zurich, Switzerland, and production takes place at sites located in the United States and Sweden. Products and services are available in over 50 countries through subsidiaries and distributors. Nobel Biocare is part the Envista family, one of the largest global dental products companies with more than 30 trusted dental brands. For more information, please visit https://www.nobelbiocare.com.

Related articles